ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSelling/general/admin expenses2.65 M1.74 M2.12 M1.57 M1.57 M7 MResearch & development13 K09 000009 000Operating income-2.28 M530 K-501 K-1.15 M-1.38 M-2.5 MNon-Operating Income, Total-137 K01.07 M1.7 M-460 K2.31 MInterest expense, net of interest capitalized——————Non-Operating Income, excl. Interest Expenses000000Unusual income/expense-137 K01.07 M1.7 M-460 K2.31 MPretax income-4.03 M530 K570 K546 K-2.33 M-685 KEquity in earnings——————Taxes8 000———1.58 M—Non-controlling/minority interest0—————After tax other income/expense——————Net income before discontinued operations-4.06 M2.6 M-4.46 M856 K-1.34 M-2.34 MDiscontinued operations—000——Net income-4.06 M2.6 M-4.46 M856 K-1.34 M-2.34 MDilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders-4.06 M2.6 M-4.46 M856 K-1.34 M-2.34 MBasic earnings per share (Basic EPS)-2.991.9-3.260.63-0.98-1.71Diluted earnings per share (Diluted EPS)-2.991.9-3.260.62-0.97-1.71Average basic shares outstanding1.36 M1.37 M1.37 M1.37 M1.37 M5.47 MDiluted shares outstanding1.36 M1.37 M1.37 M1.37 M1.37 M5.47 MEBITDA-1.94 M750 K-477 K-1.14 M-1.38 M-2.25 MEBIT-1.93 M737 K-492 K-1.15 M-1.38 M-2.28 MCost of revenue827 K682 K824 K884 K708 K3.1 MOther cost of goods sold0——00—Depreciation & amortization (cash flow)-17 K13 K15 K2 0002 00032 K
Arcadia Biosciences Inc
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.